tombal (@bertrandtombal) 's Twitter Profile
tombal

@bertrandtombal

ID: 1332642239248539648

calendar_today28-11-2020 11:08:00

191 Tweet

711 Followers

126 Following

Mirrors of Medicine (@mirrorsmed) 's Twitter Profile Photo

Gain insight into factors determining treatment appropriateness in high-risk non-metastatic #ProstateCancer 📌Check out our new case-based #CME course: ppcp.mirrorsmed.org/en/topic/pzo0k… 📽️ Including 2 cases with a video discussion by Johan Stranne Vérane Achard OncoAlert

Gain insight into factors determining treatment appropriateness in high-risk non-metastatic #ProstateCancer

📌Check out our new case-based #CME course: ppcp.mirrorsmed.org/en/topic/pzo0k…

📽️ Including 2 cases with a video discussion by <a href="/stranne_johan/">Johan Stranne</a> 

<a href="/Achard_Verane/">Vérane Achard</a> 
<a href="/OncoAlert/">OncoAlert</a>
Emre Yekedüz (@yekeduz_emre) 's Twitter Profile Photo

📌Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials: ✴️3604 patients ☢️Radiotherapy + long term ADT ❗️Gleason score ≥8 ; cN1; cT3–4; and PSA >20 ng/ml were associated with poorer outcomes!! ‼️Pts with two to

📌Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials:

✴️3604 patients

☢️Radiotherapy + long term ADT

❗️Gleason score ≥8 ; cN1;  cT3–4; and PSA &gt;20 ng/ml were associated with poorer outcomes!!

‼️Pts with two to
Adam B. Weiner, MD (@adam_weiner535) 's Twitter Profile Photo

🚨Risk Stratification of Patients with Recurrence After Primary Treatment for #ProstateCancer🚨 European Urology ✍️Systematic Review of prospective data 👉Recurrence after PCa tx can be difficult to prognosticate Risk factors w/ at least moderate evidence include:

🚨Risk Stratification of Patients with Recurrence After Primary Treatment for #ProstateCancer🚨

<a href="/EUplatinum/">European Urology</a> 

✍️Systematic Review of prospective data

👉Recurrence after PCa  tx can be difficult to prognosticate

Risk factors w/ at least moderate evidence include:
tombal (@bertrandtombal) 's Twitter Profile Photo

All Biochemical Recurrences Are Equal, but Some Are More Equal than Others sciencedirect.com/science/articl… A honor to comment on the superb review by Adam B. Weiner, MD Vérane Achard European Urology

Gil Morgan, MD (@weoncologists) 's Twitter Profile Photo

Day One of #GUARDSymposium2024 🚨 tombal 🇧🇪 Discussing: Have we reached a plateau in treatment intensification in mHSPC?: The role of de- escalation strategies GUARD Consortium 🇪🇸

Cristiane D Bergerot (@crisbergerot) 's Twitter Profile Photo

Stellar talk by Paulo G Bergerot on exercise in oncology for patients with renal cell carcinoma ANZUP #ANZUP24 This program has significantly improved patients’ quality of life and mitigated symptom burden

Stellar talk by <a href="/PauloBergerot/">Paulo G Bergerot</a> on exercise in oncology for patients with renal cell carcinoma <a href="/ANZUPtrials/">ANZUP</a> #ANZUP24
This program has significantly improved patients’ quality of life and mitigated symptom burden
tombal (@bertrandtombal) 's Twitter Profile Photo

The endless debate in patients with BCR after radical treatment: Do Not EMBARK on When, If the Answer Is How | Journal of Clinical Oncology . ascopubs.org/doi/10.1200/JC… Gianluca Giannarini

David Einstein (@davidjeinstein) 's Twitter Profile Photo

tombal Gianluca Giannarini Thanks for keeping the debate alive! Let us question the When as well as the How. BCR is a tough space that deserves its own designs and endpoints, and a nuanced approach with patients. Ravi A Madan M.D. ascopubs.org/doi/10.1200/JC…

Nicholas van As (@nickva1) 's Twitter Profile Photo

#PACE A published in European Urology! SBRT vs Radical prostatectomy. Spread the word #SBRT should be discussed with eligible patients ⁦Dr Shaun TolanAlison Tree 💙⁩ ⁦Clive PeedellDr. Andrew Loblaw⁩ ⁦Prof Emma HallProf Joe O'Sullivan⁩ authors.elsevier.com/sd/article/S03…

#PACE A published in European Urology! SBRT vs Radical prostatectomy. Spread the word #SBRT should be discussed with eligible patients ⁦<a href="/DrTolan/">Dr Shaun Tolan</a>⁩ <a href="/alison_tree/">Alison Tree 💙</a>⁩ ⁦<a href="/cpeedell/">Clive Peedell</a>⁩ <a href="/DrAndrewLoblaw/">Dr. Andrew Loblaw</a>⁩ ⁦<a href="/EmmaHall71/">Prof Emma Hall</a>⁩ <a href="/ProfJOSullivan/">Prof Joe O'Sullivan</a>⁩ authors.elsevier.com/sd/article/S03…